Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model

Journal of Dermatological Science

Volumn 80, Issue 1, 2015, Pages 45-53

  Mizuno, Kazuko ^a   Morizane, Shin ^a   Takiguchi, Tetsuya ^a,b   Iwatsuki, Keiji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Calcineurin inhibitor; Glucocorticosteroid; Psoriasis; Thymic stromal lymphopoietin; Tumor necrosis factor

Indexed keywords

CYTOKINE; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 36 GAMMA; INTERLEUKIN 6; INTERLEUKIN 8; PICRYL CHLORIDE; TACROLIMUS; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; AUTOCRINE EFFECT; BAGG ALBINO MOUSE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFANT; KERATINOCYTE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; DERMATITIS, ATOPIC; DISEASE MODEL; DRUG EFFECTS; METABOLISM;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DEXAMETHASONE; DISEASE MODELS, ANIMAL; KERATINOCYTES; MALE; MICE, INBRED BALB C; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937116211     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.06.016     Document Type: Article

References (39)

1. Brandt E.B., Sivaprasad U. Th2 cytokines and atopic dermatitis. J. Clin. Cell. Immunol. 2011, 2:110.
2. Cork M.J., Danby S.G., Vasilopoulos Y., Hadgraft J., Lane M.E., Moustafa M., et al. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 2009, 129:1892-1908.
3. Ogg G. Role of T cells in the pathogenesis of atopic dermatitis. Clin. Exp. Allergy 2009, 39:310-316.
4. [4] Hatano Y., Terashi H., Arakawa S., Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J. Invest. Dermatol. 2005, 124:786-792.
5. Morizane S., Yamasaki K., Kajita A., Ikeda K., Zhan M., Aoyama Y., et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2012, 130:259-261. e251.
6. Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol. Int. 2012, 61:3-17.
7. Zhu Z., Oh M.H., Yu J., Liu Y.J., Zheng T. The role of TSLP in IL-13-induced atopic march. Sci. Rep. 2011, 1(23):1-11.
8. Wilson S.R., The L., Batia L.M., Beattie K., Katibah G.E., McClain S.P., et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 2013, 155:285-295.
9. Volpe E., Pattarini L., Martinez-Cingolani C., Meller S., Donnadieu M.H., Bogiatzi S.I., et al. Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis. J. Allergy Clin. Immunol. 2014, 134:373-381.
10. Zelová H., Hošek J. TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm. Res. 2013, 62:641-651.
11. Monaco C., Nanchahal J., Taylor P., Feldmann M. Anti-TNF therapy: past, present and future. Int. Immunol. 2015, 27:55-62.
12. Junghans V., Gutgesell C., Jung T., Neumann C. Epidermal cytokines IL-1beta, TNF-alpha, and IL-12 in patients with atopic dermatitis: response to application of house dust mite antigens. J. Invest. Dermatol. 1998, 111:1184-1188.
13. Pellegrino M., Minervini B., Musto P., Matera R., Greco A., Checchia de Ambrosio C. Tumor necrosis factor-alpha and interleukin-1 beta. Two possible mediators of allergic inflammation. Minerva Pediatr. 1996, 48:309-312.
14. Taniguchi K., Yamamoto S., Hitomi E., Inada Y., Suyama Y., Sugioka T., et al. Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis. J. Invest. Allergol. Clin. Immunol. 2013, 23:428-434.
15. Carrier Y., Ma H.L., Ramon H.E., Napierata L., Small C., O'Toole M., et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J. Invest. Dermatol. 2011, 131:2428-2437.
16. Kutsch C.L., Norris D.A., Arend W.P. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J. Invest. Dermatol. 1993, 101:79-85.
17. Young C.N., Koepke J.I., Terlecky L.J., Borkin M.S., Boyd Savoy L., Terlecky S.R. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J. Invest. Dermatol. 2008, 128:2606-2614.
18. Kondo S., Sauder D.N. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Eur. J. Immunol. 1997, 27:1713-1718.
19. Lisby S., Hauser C. Transcriptional regulation of tumor necrosis factor-alpha in keratinocytes mediated by interleukin-1beta and tumor necrosis factor-alpha. Exp. Dermatol. 2002, 11:592-598.
20. Storey A., McArdle F., Friedmann P.S., Jackson M.J., Rhodes L.E. Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF-alpha-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts. J. Invest. Dermatol. 2005, 124:248-255.
21. Xie Y., Takai T., Chen X., Okumura K., Ogawa H. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J. Dermatol. Sci. 2012, 66:233-237.
22. Danso M.O., van Drongelen V., Mulder A., van Esch J., Scott H., van Smeden J., et al. TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J. Invest. Dermatol. 2014, 134:1941-1950.
23. Carr W.W. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr. Drugs 2013, 15:303-310.
24. Gutfreund K., Bienias W., Szewczyk A., Kaszuba A. Topical calcineurin inhibitors in dermatology. Part I: properties, method and effectiveness of drug use. Postepy Dermatol. Alergol. 2013, 30:165-169.
25. Watson W., Kapur S. Atopic dermatitis. Allergy Asthma Clin. Immunol. 2011, 7(Suppl. 1):S4.
26. Kitagaki H., Ono N., Hayakawa K., Kitazawa T., Watanabe K., Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 1997, 159:2484-2491.
27. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003, 361:151-160.
28. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J. Exp. Med. 2006, 203:269-273.
29. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
30. Lee H.C., Ziegler S.F. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:914-919.
31. Briot A., Deraison C., Lacroix M., Bonnart C., Robin A., Besson C., et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 2009, 206:1135-1147.
32. Jang Y., Jeong S.H., Park Y.H., Bae H.C., Lee H., Ryu W.I., et al. UVB induces HIF-1alpha-dependent TSLP expression via the JNK and ERK pathways. J. Invest. Dermatol. 2013, 133:2601-2608.
33. Ackermann L., Harvima I.T. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch. Dermatol. Res. 1998, 290:353-359.
34. Norris D.A. Mechanisms of action of topical therapies and the rationale for combination therapy. J. Am. Acad. Dermatol. 2005, 53:S17-S25.
35. Le T.A., Takai T., Vu A.T., Kinoshita H., Ikeda S., Ogawa H., et al. Glucocorticoids inhibit double-stranded RNA-induced thymic stromal lymphopoietin release from keratinocytes in an atopic cytokine milieu more effectively than tacrolimus. Int. Arch. Allergy Immunol. 2010, 153:27-34.
36. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
37. Al-Daraji W.I., Grant K.R., Ryan K., Saxton A., Reynolds N.J. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J. Invest. Dermatol. 2002, 118:779-788.
38. Santini M.P., Talora C., Seki T., Bolgan L., Dotto G.P. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9575-9580.
39. Hirano T. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2010, 86:717-730.